"description","identifier","uuid:ID","label","id","name","text","instanceType"
"The study age criterion","1","7221b186-8a5b-46fe-9815-aee13d9dd598","","EligibilityCriteria_1","Age Criteria","Subjects shall be between [min_age] and [max_age]","ELIGIBILITY_CRITERIA"
"The study population criterion","2","1591bf6c-ae9a-42f2-8c09-ca989760bb70","","EligibilityCriteria_2","Pop Criteria","[StudyPopulation] as defined by the NINCDS and the ADRDA guidelines (Attachment LZZT.7)","ELIGIBILITY_CRITERIA"
"The study diagnosis criterion","3","29814d2f-c0ed-479c-9451-bb713a2557d0","","EligibilityCriteria_3","Diag Criteria","[Activity1] score of 10 to 23","ELIGIBILITY_CRITERIA"
"The previous xanomeline TTS criterion","9","9888899b-1d1b-4e97-92a6-7e214efe44fa","","EligibilityCriteria_4","Previous Criteria","Persons who have previously completed or withdrawn from this study or any other study investigating xanomeline TTS or the oral formulation of xanomeline.","ELIGIBILITY_CRITERIA"
